1. Chemical Profiling and Biological Properties of Extracts from Different Parts of Colchicum Szovitsii Subsp. Szovitsii
    Gabriele Rocchetti et al, 2019, Antioxidants CrossRef
  2. Alzheimer’s Disease Pharmacotherapy in Relation to Cholinergic System Involvement
    Gabriela Dumitrita Stanciu et al, 2019, Biomolecules CrossRef
  3. Çuha Çiçeği (Oenothera biennis) ve Tatlı Badem (Prunus dulcis Mill) Yağlarının Anti-enzim Aktivitelerinin Araştırılması
    Ebru AKKEMİK, 2020 CrossRef
  4. Chemical composition and acetylcholinesterase inhibitory potential, in silico, of Myrciaria floribunda (H. West ex Willd.) O. Berg fruit peel essential oil
    Deyzi Caroline da Silva Barbosa et al, 2020, Industrial Crops and Products CrossRef
  5. Mitochondrial Dysfunctions: A Red Thread across Neurodegenerative Diseases
    Serena Stanga et al, 2020, IJMS CrossRef
  6. The TLC-Bioautography as a Tool for Rapid Enzyme Inhibitors detection - A Review
    Barbora Legerská et al, 2020, Critical Reviews in Analytical Chemistry CrossRef
  7. Cotinine and 6-Hydroxy-L-Nicotine Reverses Memory Deficits and Reduces Oxidative Stress in Aβ25-35-Induced Rat Model of Alzheimer’s Disease
    Razvan Stefan Boiangiu et al, 2020, Antioxidants CrossRef
  8. Weaker Braking Force, A New Marker of Worse Gait Stability in Alzheimer Disease
    Qianqian Cheng et al, 2020, Front. Aging Neurosci. CrossRef
  9. Research progress on the inhibition of enzymes by polyoxometalates
    Meijuan Zhao et al, 2020, Inorg. Chem. Front. CrossRef
  10. Neurobiochemical Cross-talk Between COVID-19 and Alzheimer’s Disease
    Mohammad Azizur Rahman et al, 2020, Mol Neurobiol CrossRef
  11. Antibiofilm and Enzyme Inhibitory Potentials of Two Annonaceous Food Spices, African Pepper (Xylopia aethiopica) and African Nutmeg (Monodora myristica)
    Alfred Ngenge Tamfu et al, 2020, Foods CrossRef
  12. Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
    Zeinab Breijyeh et al, 2020, Molecules CrossRef
  13. Polyphenols from Brown Seaweeds (Ochrophyta, Phaeophyceae): Phlorotannins in the Pursuit of Natural Alternatives to Tackle Neurodegeneration
    Mariana Barbosa et al, 2020, Marine Drugs CrossRef
  14. Alkaloids Analysis of Habranthus cardenasianus (Amaryllidaceae), Anti-Cholinesterase Activity and Biomass Production by Propagation Strategies
    Daniel Zaragoza-Puchol et al, 2021, Molecules CrossRef
  15. Away from Flatness: Unprecedented Nitrogen-Bridged Cyclopenta[a]indene Derivatives as Novel Anti-Alzheimer Multitarget Agents
    Alexander A. Titov et al, 2021, ACS Chem. Neurosci. CrossRef
  16. The Antiviral Drug Tilorone Is a Potent and Selective Inhibitor of Acetylcholinesterase
    Patricia A. Vignaux et al, 2021, Chem. Res. Toxicol. CrossRef
  17. Benefits under the Sea: The Role of Marine Compounds in Neurodegenerative Disorders.
    Mariano Catanesi et al, 2021, Mar Drugs CrossRef
  18. What role do metals play in Alzheimer's disease?
    Soghra Bagheri et al, 2021, J IRAN CHEM SOC CrossRef
  19. APOE: The New Frontier in the Development of a Therapeutic Target towards Precision Medicine in Late-Onset Alzheimer’s
    Anna Yang et al, 2021, IJMS CrossRef
  20. The Cholinergic System, the Adrenergic System and the Neuropathology of Alzheimer’s Disease
    Rola A. Bekdash, 2021, IJMS CrossRef
  21. Monoamine Oxidase Inhibitory Effects of Medicinal Plants in Management of Alzheimer's Disease
    Tuba EGE et al, 2021 CrossRef
  22. Anxiolytic, Promnesic, Anti-Acetylcholinesterase and Antioxidant Effects of Cotinine and 6-Hydroxy-L-Nicotine in Scopolamine-Induced Zebrafish (Danio rerio) Model of Alzheimer’s Disease
    Razvan Stefan Boiangiu et al, 2021, Antioxidants CrossRef
  23. Small compounds mimicking the adhesion molecule L1 improve recovery in a zebrafish demyelination model
    Suhyun Kim et al, 2021, Sci Rep CrossRef
  24. Flavonoids-Macromolecules Interactions in Human Diseases with Focus on Alzheimer, Atherosclerosis and Cancer
    Dana Atrahimovich et al, 2021, Antioxidants CrossRef
  25. Cholinergic System and Its Therapeutic Importance in Inflammation and Autoimmunity.
    Namrita Halder et al, 2021, Front Immunol CrossRef
  26. Multimodal Capture of Patient Behaviour for Improved Detection of Early Dementia: Clinical Feasibility and Preliminary Results
    Patrik Jonell et al, 2021, Front. Comput. Sci. CrossRef
  27. Surface Functionalization of PLGA Nanoparticles to Increase Transport across the BBB for Alzheimer’s Disease
    Laura Del Amo et al, 2021, Applied Sciences CrossRef
  28. Personalizing the Care and Treatment of Alzheimer’s Disease: An Overview
    Dubravka Svob Strac et al, 2021, PGPM CrossRef
  29. Medicinal Plants and Biogenic Metal Oxide Nanoparticles: A Paradigm Shift to Treat Alzheimer’s Disease
    Roby Gul et al, 2021, Coatings CrossRef
  30. Effects of the Hydroethanolic Extract of Lycopodium selago L. on Scopolamine-Induced Memory Deficits in Zebrafish
    Mihai-Vlad Valu et al, 2021, Pharmaceuticals CrossRef
  31. Bridging Cyanobacteria to Neurodegenerative Diseases: A New Potential Source of Bioactive Compounds against Alzheimer’s Disease
    Andrea Castaneda et al, 2021, Marine Drugs CrossRef
  32. Action Mechanisms of Curcumin in Alzheimer’s Disease and Its Brain Targeted Delivery
    Duygu Ege, 2021, Materials CrossRef
  33. human monoamine oxidase (hMAO) A and hMAO B inhibitors from Artemisia dracunculus L. herniarin and skimmin: human mononamine oxidase A and B inhibitors from A. dracunculus L.
    Tuba Aydin et al, 2020 CrossRef
  34. In Vitro Metabolism of Donepezil in Liver Microsomes Using Non-Targeted Metabolomics
    Sin-Eun Kim et al, 2021, Pharmaceutics CrossRef
  35. Improving Drug Delivery for Alzheimer’s Disease Through Nose-to-Brain Delivery Using Nanoemulsions, Nanostructured Lipid Carriers (NLC) and in situ Hydrogels
    Sara Cunha et al, 2021, IJN CrossRef
  36. Diabetic Theory in Anti-Alzheimer’s Drug Research and Development - Part 1: Therapeutic Potential of Antidiabetic Agents
    Agnieszka Jankowska et al, 2020, CMC CrossRef
  37. Synthesis and evaluation of novel arylisoxazoles linked to tacrine moiety: in vitro and in vivo biological activities against Alzheimer’s disease
    Arezoo Rastegari et al, 2021, Mol Divers CrossRef
  38. Dementia model mice exhibited improvements of neuropsychiatric symptoms as well as cognitive dysfunction with neural cell transplantation
    Masanori A. Murayama et al, 2021, Exp. Anim. CrossRef
  39. Cardiometabolic Modification of Amyloid Beta in Alzheimer’s Disease Pathology
    Marleigh Hefner et al, 2021, Front. Aging Neurosci. CrossRef
  40. Chemical Composition and Antioxidant, Anti-Inflammatory, and Enzyme Inhibitory Activities of an Endemic Species from Southern Algeria: Warionia saharae
    Habiba Rechek et al, 2021, Molecules CrossRef
  41. Novel Sulfonamide-Based Carbamates as Selective Inhibitors of BChE
    Pratibha Magar et al, 2021, IJMS CrossRef
  42. Mesenchymal Stem Cell Therapy for Alzheimer’s Disease
    A. E. Hernández et al, 2021, Stem Cells International CrossRef
  43. Calibrating Mini-Mental State Examination Scores to Predict Misdiagnosed Dementia Patients
    Akhilesh Vyas et al, 2021, Applied Sciences CrossRef
  44. Development of a Capillary Electrophoretic Method for the Determination of Huperzine A Concentration in Vietnamese Huperzia serrata
    Ngoc Chuong Nguyen et al, 2021, Natural Product Communications CrossRef
  45. Erythropoietin and Non-Erythropoietic Derivatives in Cognition
    Samuel S. Newton et al, 2021, Front. Pharmacol. CrossRef
  46. Computational and Experimental Assessments of Magnolol as a Neuroprotective Agent and Utilization of UiO-66(Zr) as Its Drug Delivery System
    Joshua Santos et al, 2021, ACS Omega CrossRef
  47. Comprehensive Biological and Chemical Evaluation of Two Seseli Species (S. gummiferum and S. transcaucasicum)
    Gokhan Zengin et al, 2021, Antioxidants CrossRef
  48. Therapeutic Potential of Human Stem Cell Implantation in Alzheimer’s Disease
    Hau Jun Chan et al, 2021, IJMS CrossRef
  49. Phytochemical Constituents and Biological Activities of the Unexplored Plant Rhinanthus angustifolius subsp. grandiflorus
    Leilei Zhang et al, 2021, Applied Sciences CrossRef
  50. Neuroprotective Potential of Mung Bean (Vigna radiata L.) Polyphenols in Alzheimer’s Disease: A Review
    Hui Xu et al, 2021, J. Agric. Food Chem. CrossRef
  51. Can Ketogenic Diet Improve Alzheimer's Disease? Association With Anxiety, Depression, and Glutamate System
    Jose Enrique de la Rubia Ortí et al, 2021, Front. Nutr. CrossRef
  52. Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases
    Claudia Riccardi et al, 2021, Pharmaceutics CrossRef
  53. The Amaryllidaceae alkaloids: an untapped source of acetylcholinesterase inhibitors
    Strahil Berkov et al, 2021, Phytochem Rev CrossRef
  54. Exploring the Binding Pattern of Geraniol with Acetylcholinesterase through In Silico Docking, Molecular Dynamics Simulation, and In Vitro Enzyme Inhibition Kinetics Studies
    Danish Iqbal et al, 2021, Cells CrossRef
  55. Current Understanding of the Physiopathology, Diagnosis and Therapeutic Approach to Alzheimer’s Disease
    Victoria García-Morales et al, 2021, Biomedicines CrossRef
  56. Anti-Amnesic Effects of Epigallocatechin Gallate on Scopolamine-Induced Learning and Memory Dysfunction in Sprague-Dawley Rats
    Min-Jeong Kim et al, 2021, Antioxidants CrossRef
  57. Identification and Quantification, Metabolism and Pharmacokinetics, Pharmacological Activities, and Botanical Preparations of Protopine: A Review
    Wangli Huang et al, 2021, Molecules CrossRef
  58. In Silico Design of Dual-Binding Site Anti-Cholinesterase Phytochemical Heterodimers as Treatment Options for Alzheimer’s Disease
    Hafsa Amat-ur-Rasool et al, 2021, CIMB CrossRef
  59. Inhibitory Mechanism of Baicalein on Acetylcholinesterase: Inhibitory Interaction, Conformational Change, and Computational Simulation
    Yijing Liao et al, 2022, Foods CrossRef
  60. Association of Circulating Magnesium Levels in Patients With Alzheimer's Disease From 1991 to 2021: A Systematic Review and Meta-Analysis
    Ke Du et al, 2022, Front. Aging Neurosci. CrossRef
  61. Pure Tone Audiometry and Hearing Loss in Alzheimer's Disease: A Meta-Analysis
    Susanna S. Kwok et al, 2022, Front. Psychol. CrossRef
  62. Solid State Stability and Preformulation Studies for Acetylcholinesterase Inhibitor Drug Tacrine
    Denisa Circioban et al, 2020, Timisoara Med CrossRef
  63. CRIDECO Anticholinergic Load Scale: An Updated Anticholinergic Burden Scale. Comparison with the ACB Scale in Spanish Individuals with Subjective Memory Complaints
    Hernán Ramos et al, 2022, JPM CrossRef
  64. Phytochemical Screening of Rosmarinus officinalis L. as a Potential Anticholinesterase and Antioxidant–Medicinal Plant for Cognitive Decline Disorders
    Majid Rasool Kamli et al, 2022, Plants CrossRef
  65. Therapeutic Efficacies of Berberine against Neurological Disorders: An Update of Pharmacological Effects and Mechanisms
    Jia-Wen Shou et al, 2022, Cells CrossRef
  66. null
    Mesut Işık, 2022 CrossRef
  67. A Brief Review of Machine Learning-Based Bioactive Compound Research
    Jihye Park et al, 2022, Applied Sciences CrossRef
  68. Attenuation of Scopolamine-Induced Amnesia via Cholinergic Modulation in Mice by Synthetic Curcumin Analogs
    Haya Hussain et al, 2022, Molecules CrossRef
  69. null
    Sabarisah Hashim et al, 2022 CrossRef
  70. Ameliorative effect of ethanol extract of Eragrostis tremula Hochst. ex Steud. against diazepam-induced amnesia in mice
    Abdullahi Balarabe Nazifi et al, 2022, Bull Natl Res Cent CrossRef
  71. In Vitro and In Silico Anti-Acetylcholinesterase Activity from Macaranga tanarius and Syzygium jambos
    Mira Syahfriena Amir Rawa et al, 2022, Molecules CrossRef
  72. Spectroscopic Evaluation of the Potential Neurotoxic Effects of a New Candidate for Anti-Seizure Medication—TP-315 during Chronic Administration (In Vivo)
    Mikolaj Krysa et al, 2022, IJMS CrossRef
  73. In Silico Screening of Cinnamon (Cinnamomum burmannii) Bioactive Compounds as Acetylcholinesterase Inhibitors
    Zatta Yumni Ihdhar Syarafina et al, 2022, J. Kim. Sains Apl. CrossRef
  74. Diosmetin Targeted at Peroxisome Proliferator-Activated Receptor Gamma Alleviates Advanced Glycation End Products Induced Neuronal Injury
    Mei Chou Lai et al, 2022, Nutrients CrossRef
  75. Assess of Combinations of Non-Pharmacological Interventions for the Reduction of Irritability in Patients with Dementia and their Caregivers: A Cross-Over RCT
    Tatiana Dimitriou et al, 2022, Brain Sciences CrossRef
  76. Biological Potential, Gastrointestinal Digestion, Absorption, and Bioavailability of Algae-Derived Compounds with Neuroprotective Activity: A Comprehensive Review
    Bruna Martins et al, 2022, Marine Drugs CrossRef
  77. Alzheimer’s Disease, Hearing Loss, and Deviance Detection
    David Pérez-González et al, 2022, Front. Neurosci. CrossRef
  78. Cognitive and physical benefits of a game‐like dual‐task exercise among the oldest nursing home residents in Japan
    Jieun Yoon et al, 2022, A&D Transl Res & Clin Interv CrossRef
  79. Assessment of Neurodegenerative Changes in Turkeys Fed Diets with Different Proportions of Arginine and Methionine Relative to Lysine
    Magdalena Krauze et al, 2022, Animals CrossRef
  80. Ex Vivo and In Vivo Study of Some Isoquinoline Precursors
    Miglena Milusheva et al, 2022, Sci. Pharm. CrossRef
  81. Diterpenoid Caesalmin C Delays Aβ-Induced Paralysis Symptoms via the DAF-16 Pathway in Caenorhabditis elegans
    Zong-Ping Zhang et al, 2022, IJMS CrossRef
  82. Bioavailability of Hesperidin and Its Aglycone Hesperetin—Compounds Found in Citrus Fruits as a Parameter Conditioning the Pro-Health Potential (Neuroprotective and Antidiabetic Activity)—Mini-Review
    Kamil Wdowiak et al, 2022, Nutrients CrossRef
  83. Synthesis of novel carboxamide- and carbohydrazide-benzimidazoles as selective butyrylcholinesterase inhibitors
    Ozum Ozturk et al, 2022, Mol Divers CrossRef
  84. Synthesis and QSAR of Novel Ketoprofen–Chalcone-Amide Hybrides as Acetylcholinesterase (AChE) Inhibitors for Possible Treatment of Alzheimer Disease
    S. K. Al-Mosawi et al, 2022, Russ J Bioorg Chem CrossRef
  85. Protective Effects of Polysaccharides in Neurodegenerative Diseases
    Yinying Wang et al, 2022, Front. Aging Neurosci. CrossRef
  86. Nootropic effect of Syzygium polyanthum (Wight) Walp leaf extract in chronic cerebral hypoperfusion rat model via cholinergic restoration: a potential therapeutic agent for dementia
    Kesevan Rajah Kumaran et al, 2022, ADV TRADIT MED (ADTM) CrossRef
  87. Acetyl-cholinesterase-inhibitors slow cognitive decline and decrease overall mortality in older patients with dementia
    Marco Zuin et al, 2022, Sci Rep CrossRef
  88. Assessments of Ceanothanes Triterpenes as Cholinesterase Inhibitors: An Investigation of Potential Agents with Novel Inspiration for Drug Treatment of Neurodegenerative Diseases
    Evelyn Muñoz-Nuñez et al, 2022, Metabolites CrossRef
  89. Effect of multicomponent exercise in cognitive impairment: a systematic review and meta-analysis
    Luis Carlos Venegas-Sanabria et al, 2022, BMC Geriatr CrossRef
  90. Advances on Therapeutic Strategies for Alzheimer’s Disease: From Medicinal Plant to Nanotechnology
    Nasser A. Hassan et al, 2022, Molecules CrossRef
  91. New Possibilities in the Therapeutic Approach to Alzheimer’s Disease
    Julia Doroszkiewicz et al, 2022, IJMS CrossRef
  92. Donepezil Beyond Alzheimer's Disease? A Narrative Review of Therapeutic Potentials of Donepezil in Different Diseases
    Parham Pooladgar et al, 2022, Iran J Pharm Res CrossRef
  93. Neuroprotective Potential of Thinned Peaches Extracts Obtained by Pressurized Liquid Extraction after Different Drying Processes
    Chongting Guo et al, 2022, Foods CrossRef
  94. 2,4-Diacetylphloroglucinol Reduces Beta-Amyloid Production and Secretion by Regulating ADAM10 and Intracellular Trafficking in Cellular and Animal Models of Alzheimer’s Disease
    Bong-Geum Jang et al, 2022, Cells CrossRef
  95. Synthesis and Cholinesterase Inhibitory Potentials of (5-formylfuran-2-yl) methyl 3,4-dimethoxy/nitro benzoates
    Mehmet KOCA, 2022, Iğdır Üniv. Fen Bil Enst. Der. CrossRef
  96. Protective Effects of Flavonoids against Alzheimer’s Disease: Pathological Hypothesis, Potential Targets, and Structure–Activity Relationship
    Jiao Li et al, 2022, IJMS CrossRef
  97. Neuroprotective effects of total alkaloids fraction of Huperzia serrata on scopolamine‐induced neurodegenerative animals
    Thu Kim Dang et al, 2022, Phytotherapy Research CrossRef
  98. The Aqueous Extract of Humulus japonicus Ameliorates Cognitive Dysfunction in Alzheimer's Disease Models via Modulating the Cholinergic System
    Chang Muk Kang et al, 2022, Journal of Medicinal Food CrossRef
  99. Effect of Vildagliptin on Cognitive Deficits in an Experimental Model of Alzheimer’s Disease
    Devasrita Dash et al, 2022, Biomed. Pharmacol. J. CrossRef
  100. Nanoporous Membranes for the Filtration of Proteins from Biological Fluids: Biocompatibility Tests on Cell Cultures and Suggested Applications for the Treatment of Alzheimer’s Disease
    Thomas Gabriel Schreiner et al, 2022, JCM CrossRef
  101. Amyloid β, Lipid Metabolism, Basal Cholinergic System, and Therapeutics in Alzheimer’s Disease
    Victoria Campos-Peña et al, 2022, IJMS CrossRef
  102. Novel small molecular compound 2JY-OBZ4 alleviates AD pathology in cell models via regulating multiple targets
    Qian Guo et al, 2022, Aging CrossRef
  103. The Chemotype of Chromanones as a Privileged Scaffold for Multineurotarget Anti-Alzheimer Agents
    Tim Keuler et al, 2022, ACS Pharmacol. Transl. Sci. CrossRef
  104. Is Caperatic Acid the Only Compound Responsible for Activity of Lichen Platismatia glauca within the Nervous System?
    Elżbieta Studzińska-Sroka et al, 2022, Antioxidants CrossRef
  105. Validation of an SH‐SY5Y Cell–Based Acetylcholinesterase Inhibition Assay for Water Quality Assessment
    Jungeun Lee et al, 2022, Enviro Toxic and Chemistry CrossRef
  106. Hyperinsulinemia-induced microglial mitochondrial dynamic and metabolic alterations lead to neuroinflammation in vivo and in vitro
    Xiaohan Yang et al, 2022, Front. Neurosci. CrossRef
  107. null
    Neerav Chaudhary et al, 2022 CrossRef
  108. null
    Nguyen van Hoan Duy et al, 2022 CrossRef
  109. Pretreatment of rhesus monkeys with transdermal patches containing physostigmine and procyclidine: implications of the delivery system for the potential application against VX nerve agent intoxication in humans
    Ji-Hye Nam et al, 2023, Arch Toxicol CrossRef
  110. Molecular mechanisms of Alzheimer's disease: From therapeutic targets to promising drugs
    Elif Alan et al, 2023, Fundamemntal Clinical Pharma CrossRef
  111. M1/M4-Preferring Muscarinic Cholinergic Receptor Agonist Xanomeline Reverses Wake and Arousal Deficits in Nonpathologically Aged Mice
    Jason K. Russell et al, 2023, ACS Chem. Neurosci. CrossRef
  112. Para-Substituted Thiosemicarbazones as Cholinesterase Inhibitors: Synthesis, In Vitro Biological Evaluation, and In Silico Study
    Momin Khan et al, 2023, ACS Omega CrossRef
  113. Therapeutic potential of blackberry extract in the preventing memory deficits and neurochemical alterations in the cerebral cortex, hippocampus and cerebellum of a rat model with amnesia
    Julia Eisenhardt de Mello et al, 2023, Metab Brain Dis CrossRef
  114. Traversing through the cell signaling pathways of neuroprotection by betanin: therapeutic relevance to Alzheimer’s Disease and Parkinson’s Disease
    Banashree Chetia Phukan et al, 2023, Metab Brain Dis CrossRef
  115. Evaluation of antioxidant potentials and acetylcholinesterase inhibitory effects of some new salicylic acid-salicylamide hybrids
    Mehmet Koca et al, 2023, J IRAN CHEM SOC CrossRef
  116. Alzheimer’s Disease and Stem Cell Therapy
    Jingyao Liao, 2023, HSET CrossRef
  117. Acetylcholinesterase Inhibition Properties and Docking Studies of Compounds Based on 6-Hydrazinyl-1,3,4-Trimethyl-1H-Pyrazolo[3,4-b]Pyridine
    Seyit Ali GÜNGÖR, 2023, JOTCSA CrossRef
  118. Neuroprotective Activity of Ethanolic Extract of Red Ginger Containing 6-Shogaol on Scopolamine-Induced Memory Impairment in Alzheimer's Mice
    Fifteen Aprila Fajrin et al, 2023, Biomed. Pharmacol. J. CrossRef
  119. A Review on Recent Development of Novel Heterocycles as Acetylcholinesterase Inhibitor for the Treatment of Alzheimer’s Disease
    Ashish Patel et al, 2023, CDT CrossRef
  120. The potential of culinary herbs and spices from the genera Curcuma and Zingiber in the management of type 2 diabetes mellitus and Alzheimer’s disease
    Yasodha Sivasothy et al, 2023, Journal of Essential Oil Research CrossRef
  121. The promising guide to LC–MS analysis and cholinesterase activity of Luffa cylindrica (L.) fruit using in vitro and in-silico analyses
    S. Ankul Singh et al, 2023, Futur J Pharm Sci CrossRef
  122. Rumo a uma nova era no diagnóstico e tratamento da doença de Alzheimer
    João Pedro Ferrari-Souza et al, 2023, PAJAR CrossRef
  123. Methoxy-naphthyl-Linked N-Benzyl Pyridinium Styryls as Dual Cholinesterase Inhibitors: Design, Synthesis, Biological Evaluation, and Structure–Activity Relationship
    Mohd Abdullaha et al, 2023, ACS Omega CrossRef
  124. The fusiform gyrus exhibits differential gene-gene co-expression in Alzheimer's disease
    Arthur Ribeiro-dos-Santos et al, 2023, Front. Aging Neurosci. CrossRef
  125. DISCOVERY OF DONEPEZIL-LIKE COMPOUNDS AS POTENTIAL ACETYLCHOLINESTERASE INHIBITORS DETERMINED BY PHARMACOPHORE MAPPING-BASED VIRTUAL SCREENING AND MOLECULAR DOCKING
    Ferah CÖMERT ÖNDER, 2023 CrossRef
  126. Neurotransmitter Systems in the Etiology of Major Neurological Disorders: Emerging Insights and Therapeutic Implications
    Mallikarjuna Nimgampalle et al, 2023, Ageing Research Reviews CrossRef
  127. Putting the Puzzle Together To Get the Whole Picture: Molecular Basis of the Affinity of Two Steroid Derivatives to Acetylcholinesterase
    Victoria Richmond et al, 2023, ACS Omega CrossRef
  128. Advances in diagnosing mild cognitive impairment and Alzheimer’s disease using 11C-PIB- PET/CT and common neuropsychological tests
    Qing Zhao et al, 2023, Front. Neurosci. CrossRef
  129. The past and present of therapeutic strategy for Alzheimer’s diseases: potential for stem cell therapy
    Masanori A. Murayama, 2023, Exp. Anim. CrossRef
  130. Catecholamine Derivatives: Natural Occurrence, Structural Diversity, and Biological Activity
    Kai-Jun Tang et al, 2023, J. Nat. Prod. CrossRef
  131. Bioactivity-guided isolation of anti-acetylcholinesterase compounds from Odontites vulgaris Moench
    Liang Liu et al, 2023, Med Chem Res CrossRef
  132. Modern approaches to pharmacotherapy of alzheimer's disease
    Gleb S. Davydov et al, 2023, Scientific Bulletin of the Omsk State Medical University CrossRef
  133. Design, Synthesis, and Pharmacological Evaluation of Novel Tacrine Derivatives as Multi-target ANTI-Alzheimer’s Agents In Rat Models
    Remya R.S. et al, 2023, CNSAMC CrossRef
  134. Pathophysiological Aspects and Therapeutic Armamentarium of Alzheimer’s Disease: Recent Trends and Future Development
    Bhavarth P. Dave et al, 2023, Cell Mol Neurobiol CrossRef
  135. Manejo Farmacológico De Pacientes Com Doença De Alzheimer: Revisão Narrativa Da Literatura
    Lana Omar Ghazzaoui et al, 2023, jmrr CrossRef
  136. Synthesis, Antiacetylcholinesterase Activity, and Molecular Dynamics Simulation of Aporphine–benzylpyridinium Conjugates
    Nisachon Khunnawutmanotham et al, 2023, ACS Med. Chem. Lett. CrossRef
  137. null
    Kahkashan Tabassum et al, 2023 CrossRef
  138. Chemical profile, enzyme inhibitory and antioxidant activities of essential oils of an endemic Algerian species : Abies numidica . De Lannoy ex Carrière
    Abdenour Adjaoud et al, 2023, Journal of Essential Oil Research CrossRef
  139. Exploring avenues for Alzheimer’s drugs: current status and future outlook
    K. Rathi et al, 2024, РНЖ CrossRef
  140. Acetylcholine modulates the precision of prediction error in the auditory cortex
    David Pérez-González et al, 2024 CrossRef
  141. Acetylcholine modulates the precision of prediction error in the auditory cortex
    David Pérez-González et al, 2024 CrossRef
  142. A galantamine–curcumin hybrid lacks the depressant side effect of acetylcholinesterase inhibitors
    Ivanka Kostadinova et al, 2024, Biotechnology & Biotechnological Equipment CrossRef
  143. COP-22 Alleviates d-Galactose–Induced Brain Aging by Attenuating Oxidative Stress, Inflammation, and Apoptosis in Mice
    Yazhong Ma et al, 2024, Mol Neurobiol CrossRef
  144. A recent update on huprine and its hybrids as a potential multifunctional agent for the treatment of Alzheimer's disease
    Yash Pal Singh et al, 2024, Chem Biol Drug Des CrossRef
  145. Novel Dual-Acting Hybrids Targeting Type-2 Cannabinoid Receptors and Cholinesterase Activity Show Neuroprotective Effects In Vitro and Amelioration of Cognitive Impairment In Vivo
    Claudia Mugnaini et al, 2024, ACS Chem. Neurosci. CrossRef